- Enovis to Participate in Investor Conferences in June
- Enovis Announces First Quarter 2023 Results
- Enovis to Host First Quarter 2023 Results Conference Call on May 4th
- Enovis to Acquire Novastep
- ENOVIS™ Showcases Next Generation of Medical Technology at the American Academy of Orthopaedic Surgeons (AAOS) Annual Meeting
- Newsweek Names Enovis™ as One of America’s Greatest Workplaces for Diversity 2023
- Enovis™ to Showcase Latest Innovations and Growing Foot & Ankle Portfolio at ACFAS 2023
- Enovis Expands Foot & Ankle Portfolio’s DynaClip® Family by Introducing Procedure-Specific Staples
- Enovis to Participate in the 41st Annual J.P. Morgan Healthcare Conference
- Enovis Receives FDA Approval of Patient Specific Instrumentation for STAR® Ankle
More ▼
Key statistics
As of last trade Enovis Corp (ENOV:NYQ) traded at 55.69, -17.28% below its 52-week high of 67.32, set on Jun 07, 2022.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 55.64 |
---|---|
High | 55.84 |
Low | 55.47 |
Bid | 55.75 |
Offer | 56.02 |
Previous close | 55.43 |
Average volume | 373.13k |
---|---|
Shares outstanding | 54.50m |
Free float | 48.01m |
P/E (TTM) | -- |
Market cap | 3.02bn USD |
EPS (TTM) | -0.4469 USD |
Data delayed at least 15 minutes, as of Jun 07 2023 14:42 BST.
More ▼